Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$462M |
| 2 |
AGN
Allergan plc
AGN
|
+$390M |
| 3 |
AT&T
T
|
+$371M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$353M |
| 5 |
NextEra Energy
NEE
|
+$326M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.97B |
| 2 |
Meta Platforms (Facebook)
META
|
+$435M |
| 3 |
Pfizer
PFE
|
+$377M |
| 4 |
GE Aerospace
GE
|
+$354M |
| 5 |
Starbucks
SBUX
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 9.79% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Bio-Rad Laboratories Class A
BIO
$9.66B
| $21.6M | 0.02% |
61,700
-16,700
| -21% | -$6.14M |
|
727
Anika Therapeutics
ANIK
$283M
| $21.6M | 0.02% |
747,829
+162,700
| +28% | +$6.58M |
|
728
CRISPR Therapeutics
CRSP
$5.22B
| $21.6M | 0.02% |
509,175
+114,611
| +29% | +$5.92M |
|
729
Dine Brands
DIN
$440M
| $21.6M | 0.02% |
751,900
-85,300
| -10% | -$6.18M |
|
|
FSP
730
Franklin Street Properties
FSP
$46.4M
| $21.6M | 0.02% |
3,762,097
+32,900
| +0.9% | +$233K |
|
731
Cohu
COHU
$2.76B
| $21.5M | 0.02% |
1,739,717
+168,054
| +11% | +$3.43M |
|
732
PennyMac Financial
PFSI
$4.13B
| $21.5M | 0.02% |
972,949
-30,744
| -3% | -$990K |
|
733
UFP Technologies
UFPT
$2.48B
| $21.5M | 0.02% |
564,272
+21,316
| +4% | +$979K |
|
|
ELP
734
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $21.5M | 0.02% |
5,153,500
+964,750
| +23% | +$5.94M |
|
|
SAGE
735
DELISTED
Sage Therapeutics
SAGE
| $21.5M | 0.02% |
747,132
+636,541
| +576% | +$36.9M |
|
|
QIWI
736
DELISTED
QIWI PLC
QIWI
| $21.4M | 0.02% |
1,998,351
+180,380
| +10% | +$3.08M |
|
737
TechTarget
TTGT
$277M
| $21.3M | 0.02% |
1,035,700
+94,900
| +10% | +$2.26M |
|
738
CDW
CDW
$17.8B
| $21.3M | 0.02% |
228,198
-85,527
| -27% | -$10.5M |
|
739
Calix
CALX
$2.51B
| $21.3M | 0.02% |
3,004,218
+289,700
| +11% | +$2.44M |
|
740
Berkshire Hathaway Class A
BRK.A
$1.09T
| $21.2M | 0.02% |
78
+75
| +2,500% | +$23.9M |
|
741
Phibro Animal Health
PAHC
$1.38B
| $21.1M | 0.02% |
873,800
+35,300
| +4% | +$863K |
|
742
American Eagle Outfitters
AEO
$2.73B
| $21.1M | 0.02% |
2,648,334
-1,216,720
| -31% | -$15.5M |
|
743
WesBanco
WSBC
$4.1B
| $21M | 0.02% |
887,898
-47,400
| -5% | -$1.48M |
|
744
Buckle
BKE
$2.31B
| $21M | 0.02% |
1,532,211
+595,761
| +64% | +$13.4M |
|
745
OR Royalties Inc
OR
$6.15B
| $21M | 0.02% |
2,822,275
+459,675
| +19% | +$4.09M |
|
746
MKS Inc
MKSI
$20.7B
| $20.9M | 0.02% |
257,020
-438,263
| -63% | -$44.8M |
|
747
Central Pacific Financial
CPF
$1B
| $20.9M | 0.02% |
1,315,163
+350,663
| +36% | +$8.63M |
|
748
Aurinia Pharmaceuticals
AUPH
$2.02B
| $20.9M | 0.02% |
1,438,800
+860,266
| +149% | +$15.2M |
|
|
AD
749
Array Digital Infrastructure
AD
$3.09B
| $20.9M | 0.02% |
712,462
+32,800
| +5% | +$1.07M |
|
|
GLDD
750
DELISTED
Great Lakes Dredge & Dock
GLDD
| $20.9M | 0.02% |
2,512,001
+302,900
| +14% | +$3.02M |
|
Similar funds
Jim Simons's Q1 2020 Portfolio in Review
As of Q1 2020, Jim Simons held 4,047 positions worth $103B, down 21% from $130B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jim Simons's Q1 2020 filing shows 573 new, 1,474 increased, 1,328 reduced and 645 closed positions. Its largest new stake was AT&T: 13,563,699 shares worth $299M. The largest sale was Tesla, an estimated $1.97B.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q1 2020 buy was AT&T: 13,563,699 shares worth $299M.
- Jim Simons added most to Baidu in Q1 2020, an estimated $462M increase.
- Jim Simons's biggest Q1 2020 reduction was Tesla, cutting an estimated $1.97B.
- Jim Simons fully exited Phillips 66 in Q1 2020, selling an estimated $214M.
- Jim Simons's ten largest holdings make up 15% of its $103B portfolio in Q1 2020.
- Jim Simons opened 573 new positions and closed 645 in Q1 2020.
- Jim Simons's portfolio value fell 21% quarter-over-quarter to $103B.
Based on Renaissance Technologies's 13F filing for Q1 2020, filed 14 May 2020.